IL1B and myeloid sarcoma: NMO patients have higher TNF-αlevels compared to HS (P < 0.05) and NMO patients, and MS patients had higher levels of IL-1β compared to HS (P < 0.01, P < 0.05, respectively; Figures 6A,B).